Fresenius SE Long Term Debt 2016-2024 | FSNUY

Fresenius SE long term debt from 2016 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Fresenius SE long term debt for the quarter ending June 30, 2024 was $11.811B, a 38.44% decline year-over-year.
  • Fresenius SE long term debt for 2023 was $12.4B, a 38.01% decline from 2022.
  • Fresenius SE long term debt for 2022 was $20.004B, a 1.7% increase from 2021.
  • Fresenius SE long term debt for 2021 was $19.669B, a 2.36% increase from 2020.
Fresenius SE Annual Long Term Debt
(Millions of US $)
2023 $12,400
2022 $20,004
2021 $19,669
2020 $19,215
2019 $18,036
2018 $16,581
2017 $18,246
2016 $14,212
2015 $15,109
Fresenius SE Quarterly Long Term Debt
(Millions of US $)
2024-06-30 $11,811
2024-03-31 $11,868
2023-12-31 $12,400
2023-09-30 $11,860
2023-06-30 $19,188
2023-03-31 $21,251
2022-12-31 $20,004
2022-09-30 $19,249
2022-06-30 $19,859
2022-03-31 $19,687
2021-12-31 $19,669
2021-09-30 $21,359
2021-06-30 $21,930
2021-03-31 $17,857
2020-12-31 $19,215
2020-09-30 $20,834
2020-06-30 $17,829
2020-03-31 $17,021
2019-12-31 $18,036
2019-09-30 $17,979
2019-06-30 $17,774
2019-03-31 $17,590
2018-12-31 $16,581
2018-09-30 $16,286
2018-06-30 $17,884
2018-03-31 $19,380
2017-12-31 $18,246
2017-09-30 $19,384
2017-06-30 $18,829
2017-03-31 $18,934
2016-12-31 $14,212
2016-09-30 $13,731
2016-06-30 $14,819
2016-03-31 $14,433
2015-12-31 $15,109
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.458B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00